Contact Us
Global Neorecormon Market Report 2025

Neorecormon Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Formulation (Injectable Solution, Pre-Filled Syringes), By Indication (Anemia Due To Chronic Kidney Disease (CKD), Anemia In Cancer Patients, Anemia Associated With Other Conditions), By End User Patients (Adult Patients, Pediatric Patients), By Distribution Channel (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies)

Neorecormon Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Neorecormon Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Neorecormon Market?

Neorecormon is a biopharmaceutical medication used to treat anemia caused by chronic kidney disease, chemotherapy, or other conditions that affect red blood cell production. It works as an erythropoietin-stimulating agent, promoting the production of red blood cells to improve oxygen delivery throughout the body.

The main types of formulations in neorecormon include injectable solutions and pre-filled syringes. Injectable solutions are medications that are administered directly into the body through a needle or syringe, and neorecormon, in its injectable solution form, is used to treat anemia in patients with chronic kidney disease (CKD), stimulating the production of red blood cells and improving oxygen delivery throughout the body. The indications are categorized into anemia due to chronic kidney disease (CKD), anemia in cancer patients, anemia associated with other conditions for end user patients, such as adult patients, pediatric patients with distribution channels, including hospitals, specialty clinics, retail pharmacies, and online pharmacies.

Neorecormon Market Size and growth rate 2025 to 2029: Graph

What Is The Neorecormon Market Size 2025 And Growth Rate?

The neorecormon market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to a rise in the prevalence of chronic kidney disease (CKD), increased chemotherapy-induced anemia cases, growth in the geriatric population, increased healthcare access in emerging markets, and a rise in awareness of anemia management.

What Is The Neorecormon Market Growth Forecast?

The neorecormon market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to expanding healthcare infrastructure in emerging markets, rising prevalence of chronic diseases, increasing demand for effective anemia treatments, government healthcare initiatives to support anemia management, and growth in cancer treatment leading to more chemotherapy-induced anemia cases. Major trends in the forecast period include a shift towards personalized medicine, the integration of digital health technologies in treatment management, the development of combination therapies for anemia, rising collaboration between pharmaceutical companies and healthcare providers, and advances in biosimilars and biologic therapies.

How Is The Neorecormon Market Segmented?

The neorecormon market covered in this report is segmented –

1) By Formulation: Injectable Solution; Pre-Filled Syringes

2) By Indication: Anemia Due To Chronic Kidney Disease (CKD); Anemia In Cancer Patients; Anemia Associated With Other Conditions

3) By End User Patients: Adult Patients; Pediatric Patients

4) By Distribution Channel: Hospitals; Specialty Clinics; Retail Pharmacies; Online Pharmacies

What Is Driving The Neorecormon Market? Rising Prevalence Of Chronic Kidney Disease To Drive Market Growth

The rising prevalence of chronic kidney disease (CKD) is expected to propel the neorecormon market going forward. Chronic kidney disease (CKD) is a progressive condition in which kidney function gradually declines, often leading to anemia due to reduced erythropoietin production. The rise in CKD cases is driven by factors such as an aging population and lifestyle-related diseases. Neorecormon is essential for individuals with chronic kidney disease (CKD) to manage and improve their quality of life by addressing anemia-related conditions that commonly develop as the disease progresses. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. Further, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million by 2033. Therefore, the rising prevalence of chronic kidney disease (CKD) will drive the neorecormon market.

What Is Driving The Neorecormon Market? Impact Of Healthcare Expenditures On The Market

The increasing healthcare expenditures are anticipated to propel the growth of the neorecormon market going forward. Healthcare expenditures refer to the total amount spent on healthcare-related services, products, and activities within a specified period, typically on an individual, community, national, or global level. Increasing healthcare expenditures are driven by factors such as the rising prevalence of chronic diseases, an aging population, advancements in medical technology, and growing demand for more advanced treatments and healthcare services. Increasing healthcare expenditures enhances access to treatments such as neorecormon by increasing insurance coverage, reducing patient costs, and improving funding for anemia management programs. This fosters early diagnosis, wider adoption, and market expansion, especially in emerging economies. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, in 2023, healthcare expenditure in the UK was approximately $367 billion (£292 billion), reflecting an increase of 5.6%. Additionally, long-term health and social care expenditure rose by 2.8% in real terms in 2022. Therefore, increasing healthcare expenditure will drive the neorecormon market.

What Is Driving The Neorecormon Market? Growing Aging Population To Propel Market Growth

The growing aging population is projected to fuel the neorecormon market growth going forward. Aging is a natural process marked by a gradual decline in physiological functions, making individuals more susceptible to chronic conditions such as cancer and kidney diseases, which often result in anemia. The aging population is expanding with advancements in healthcare, increased life expectancy, and declining birth rates. Neorecormon, an erythropoiesis-stimulating agent (ESA), is crucial in managing anemia by boosting red blood cell production, improving energy levels, and enhancing treatment outcomes for elderly patients. For instance, in July 2023, according to Age UK, a UK-based registered charity for older people, in 2023, there are 11 million individuals aged over 65 in England. This number is expected to rise by 10% over the next five years and by 32% by 2043, translating to an increase of 1.1 million and 3.5 million people, respectively. Therefore, the growing aging population will drive the neorecormon market.

Who Are The Major Players In The Global Neorecormon Market?

Major companies operating in the neorecormon market are F. Hoffmann-La Roche Ltd.

Regional Analysis For The Global Neorecormon Market

North America was the largest region in the neorecormon market in 2024. The regions covered in the neorecormon market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neorecormon market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Neorecormon Market?

The neorecormon market consists of sales of erythropoietin-stimulating agents in formulations such as vials, cartridges, and ampoules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neorecormon Industry?

The neorecormon market research report is one of a series of new reports from The Business Research Company that provides neorecormon market statistics, including neorecormon industry global market size, regional shares, competitors with a neorecormon market share, detailed neorecormon market segments, market trends and opportunities, and any further data you may need to thrive in the neorecormon industry. This neorecormon market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neorecormon Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The neorecormon market covered in this report is segmented –
1) By Formulation: Injectable Solution; Pre-Filled Syringes
2) By Indication: Anemia Due To Chronic Kidney Disease (CKD); Anemia In Cancer Patients; Anemia Associated With Other Conditions
3) By End User Patients: Adult Patients; Pediatric Patients
4) By Distribution Channel: Hospitals; Specialty Clinics; Retail Pharmacies; Online Pharmacies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Neorecormon Market Characteristics

    3. Neorecormon Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Neorecormon Market Trends And Strategies

    5. Neorecormon Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    6. Global Neorecormon Growth Analysis And Strategic Analysis Framework

    6.1. Global Neorecormon PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Neorecormon Market Growth Rate Analysis

    6.4. Global Neorecormon Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Neorecormon Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Neorecormon Total Addressable Market (TAM)

    7. Global Neorecormon Pricing Analysis & Forecasts

    8. Neorecormon Market Segmentation

    8.1. Global Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Injectable Solution

    Pre-Filled Syringes

    8.2. Global Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Anemia Due To Chronic Kidney Disease (CKD)

    Anemia In Cancer Patients

    Anemia Associated With Other Conditions

    8.3. Global Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult Patients

    Pediatric Patients

    8.4. Global Neorecormon Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Specialty Clinics

    Retail Pharmacies

    Online Pharmacies

    9. Global Neorecormon Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Neorecormon Market Regional And Country Analysis

    10.1. Global Neorecormon Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Neorecormon Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Neorecormon Market

    11.1. Asia-Pacific Neorecormon Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Neorecormon Market

    12.1. China Neorecormon Market Overview

    12.2. China Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Neorecormon Market

    13.1. India Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Neorecormon Market

    14.1. Japan Neorecormon Market Overview

    14.2. Japan Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Neorecormon Market

    15.1. Australia Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Neorecormon Market

    16.1. South Korea Neorecormon Market Overview

    16.2. South Korea Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Neorecormon Market

    17.1. Western Europe Neorecormon Market Overview

    17.2. Western Europe Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Neorecormon Market

    18.1. UK Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Neorecormon Market

    19.1. Germany Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Neorecormon Market

    20.1. France Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Neorecormon Market

    21.1. Eastern Europe Neorecormon Market Overview

    21.2. Eastern Europe Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Neorecormon Market

    22.1. North America Neorecormon Market Overview

    22.2. North America Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Neorecormon Market

    23.1. USA Neorecormon Market Overview

    23.2. USA Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Neorecormon Market

    24.1. Canada Neorecormon Market Overview

    24.2. Canada Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Neorecormon Market

    25.1. South America Neorecormon Market Overview

    25.2. South America Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Neorecormon Market

    26.1. Middle East Neorecormon Market Overview

    26.2. Middle East Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Neorecormon Market

    27.1. Africa Neorecormon Market Overview

    27.2. Africa Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Neorecormon Market Competitive Landscape And Company Profiles

    28.1. Neorecormon Market Competitive Landscape

    28.2. Neorecormon Market Company Profiles

    28.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Neorecormon Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Neorecormon Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Neorecormon Market

    32. Recent Developments In The Neorecormon Market

    33. Neorecormon Market High Potential Countries, Segments and Strategies

    33.1 Neorecormon Market In 2029 - Countries Offering Most New Opportunities

    33.2 Neorecormon Market In 2029 - Segments Offering Most New Opportunities

    33.3 Neorecormon Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Neorecormon Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Neorecormon Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Neorecormon Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: F. Hoffmann-La Roche Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Neorecormon Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Neorecormon Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Neorecormon Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Neorecormon Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Neorecormon Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Neorecormon Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: F. Hoffmann-La Roche Ltd. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Neorecormon market?

Neorecormon is a biopharmaceutical medication used to treat anemia caused by chronic kidney disease, chemotherapy, or other conditions that affect red blood cell production. It works as an erythropoietin-stimulating agent, promoting the production of red blood cells to improve oxygen delivery throughout the body. For further insights on the Neorecormon market, request a sample here

How will the Neorecormon market drivers and restraints affect the market dynamics? What forces will shape the Neorecormon industry going forward?

The Neorecormon market major growth driver - Rising Prevalence Of Chronic Kidney Disease To Drive Market Growth. For further insights on the Neorecormon market, request a sample here

What is the forecast market size or the forecast market value of the Neorecormon market?

The Neorecormon market size has grown strongly in recent years. The neorecormon market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to a rise in the prevalence of chronic kidney disease (CKD), increased chemotherapy-induced anemia cases, growth in the geriatric population, increased healthcare access in emerging markets, and a rise in awareness of anemia management. The neorecormon market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to expanding healthcare infrastructure in emerging markets, rising prevalence of chronic diseases, increasing demand for effective anemia treatments, government healthcare initiatives to support anemia management, and growth in cancer treatment leading to more chemotherapy-induced anemia cases. Major trends in the forecast period include a shift towards personalized medicine, the integration of digital health technologies in treatment management, the development of combination therapies for anemia, rising collaboration between pharmaceutical companies and healthcare providers, and advances in biosimilars and biologic therapies. For further insights on the Neorecormon market, request a sample here

How is the Neorecormon market segmented?

The neorecormon market covered in this report is segmented –
1) By Formulation: Injectable Solution; Pre-Filled Syringes
2) By Indication: Anemia Due To Chronic Kidney Disease (CKD); Anemia In Cancer Patients; Anemia Associated With Other Conditions
3) By End User Patients: Adult Patients; Pediatric Patients
4) By Distribution Channel: Hospitals; Specialty Clinics; Retail Pharmacies; Online Pharmacies For further insights on the Neorecormon market,
request a sample here

Which region has the largest share of the Neorecormon market? What are the other regions covered in the report?

North America was the largest region in the neorecormon market in 2024. The regions covered in the neorecormon market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Neorecormon market, request a sample here.

Who are the major players in the Neorecormon market?

Major companies operating in the neorecormon market are F. Hoffmann-La Roche Ltd. . For further insights on the Neorecormon market, request a sample here.

What are the key trends in the Neorecormon market?

Major trends in the Neorecormon market include . For further insights on the Neorecormon market, request a sample here.

What are the major opportunities in the Neorecormon market? What are the strategies for the Neorecormon market?

For detailed insights on the major opportunities and strategies in the Neorecormon market, request a sample here.

How does the Neorecormon market relate to the overall economy and other similar markets?

For detailed insights on Neorecormon's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Neorecormon industry?

For detailed insights on the mergers and acquisitions in the Neorecormon industry, request a sample here.

What are the key dynamics influencing the Neorecormon market growth? SWOT analysis of the Neorecormon market.

For detailed insights on the key dynamics influencing the Neorecormon market growth and SWOT analysis of the Neorecormon industry, request a sample here.